
Causal relationship between Helicobacter pylori infection and childhood immune thrombocytopenia and influencing factors for prognosis
Xiao-Yang ZHOU, Mei YAN, Ying-Bin YUE, Hailigulli NURIDDIN, Xue-Mei WANG, Yong-Feng CHENG, Chun-Can WU, Yu LIU
Chinese Journal of Contemporary Pediatrics ›› 2025, Vol. 27 ›› Issue (9) : 1105-1112.
Causal relationship between Helicobacter pylori infection and childhood immune thrombocytopenia and influencing factors for prognosis
Objective To investigate the causal relationship between Helicobacter pylori (Hp) infection and immune thrombocytopenia (ITP) using Mendelian randomization (MR), as well as the association between Hp infection and chronic ITP (cITP) through a clinical study. Methods The datasets from genome-wide association studies were used to select the single nucleotide polymorphism loci significantly associated with Hp infection as genetic instrumental variables. The MR analysis model was used to investigate the causal relationship between ITP and Hp infection. A retrospective analysis was conducted on the medical data of 316 children with newly diagnosed ITP at the First Affiliated Hospital of Xinjiang Medical University from January 2020 to December 2023. The children were followed up for 1 year, and a multivariate logistic regression analysis was used to investigate the risk factors for cITP. Results The inverse variance weighted analysis revealed that Hp infection was significantly associated with an increased risk of ITP (OR=1.280, 95%CI: 1.098-1.492, P=0.002). There was no heterogeneity or pleiotropy in this MR study (P>0.05), and the model was stable. The "leave-one-out" sensitivity analysis verified the reliability of the results. The multivariate logistic regression analysis demonstrated that Hp infection was an independent risk factor for progression to cITP (OR=7.916, 95%CI: 3.327-18.832, P<0.001). Conclusions Hp infection is a risk factor for the onset of ITP and is an independent risk factor for cITP in children.
Immune thrombocytopenia / Helicobacter pylori / Mendelian randomization / Clinical study / Child
[1] |
国家卫生健康委. 儿童原发性免疫性血小板减少症诊疗规范(2019年版)[J]. 全科医学临床与教育, 2019, 17(12): 1059-1062. DOI: 10.13558/j.cnki.issn1672-3686.2019.012.002 .
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
何钰珊, 林熙, 杨婉婷, 等. 免疫性血小板减少症患儿生活质量研究进展[J]. 中国小儿血液与肿瘤杂志, 2021, 26(5): 310-313, 317. DOI: 10.3969/j.issn.1673-5323.2021.05.013 .
|
[8] |
|
[9] |
|
[10] |
常明珠, 李雨澎, 母润红, 等. 幽门螺杆菌检测方法及其应用价值的研究进展[J]. 吉林大学学报(医学版), 2023, 49(1): 253-260. DOI: 10.13481/j.1671-587X.20230134 .
|
[11] |
|
[12] |
徐太军, 常友成. 幽门螺杆菌感染对机体糖代谢、脂代谢的影响[J]. 临床消化病杂志, 2023, 35(2): 141-144. DOI: 10.3870/lcxh.j.issn.1005-541X.2023.02.012 .
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
中华医学会儿科学分会消化学组, 《中华儿科杂志》编辑委员会. 儿童幽门螺杆菌感染诊治专家共识[J]. 中华儿科杂志, 2015, 53(7): 496-498. DOI: 10.3760/cma.j.issn.0578-1310.2015.07.006 .
|
[18] |
史美龄, 周敏. 儿童原发性免疫性血小板减少症的慢性病程预测分析[J]. 中国小儿血液与肿瘤杂志, 2024, 29(1): 61-65. DOI: 10.3969/j.issn.1673-5323.2024.01.013 .
|
[19] |
|
[20] |
|
[21] |
任颖, 谢萍. 儿童免疫性血小板减少症临床特征分析[J]. 中国实验血液学杂志, 2023, 31(5): 1443-1447. DOI: 10.19746/j.cnki.issn.1009-2137.2023.05.030 .
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
许晶, 严倩, 李冬云, 等. 国内抗幽门螺杆菌治疗在儿童原发免疫性血小板减少症中疗效的Meta分析和试验序贯分析[J]. 中国医院药学杂志, 2020, 40(5): 552-558. DOI: 10.13286/j.1001-5213.2020.05.16 .
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
Suppl 1
|
[32] |
|
[33] |
|
所有作者均声明无利益冲突。